SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-24-024773
Filing Date
2024-03-21
Accepted
2024-03-21 16:26:13
Documents
1
Period of Report
2024-03-15

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1500
  Complete submission text file 0001213900-24-024773.txt   3052
Mailing Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Issuer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O INTELLIA THERAPEUTICS, INC. 40 ERIE STREET, SUITE 130 CAMBRIDGE MA 02139
Business Address
GOODMAN JESSE (Reporting) CIK: 0001756929 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38762 | Film No.: 24771751